Zyprexa Tablet
Product Images NDC 61269-635

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zyprexa (NDC 61269-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (ZYPREXA 10 mg tablet, bottle of 30)

Zyprexa 10 mg oral tablets label showing the product name, active ingredient olanzapine, and strength 10 mg. The label indicates a package of 30 tablets, with the labeler H2-Pharma LLC and licensee CHEPLAPHARM. It includes storage instructions and a note that the medication guide should be dispensed to patients. The NDC number is 61269-633-30.*

FDA Label Image

Package Label (ZYPREXA 15 mg tablet, bottle of 30)

Label for Zyprexa 15 mg tablets containing olanzapine, with 30 tablets per bottle. The label features the brand name Zyprexa prominently, active ingredient olanzapine, and strength 15 mg. It is distributed by H2-Pharma LLC and licensed by CHEPLAPHARM. The label includes storage instructions, a warning about the inner seal, and a barcode with NDC 61269-634-30.*

FDA Label Image

Package Label (ZYPREXA 2.5 mg tablet, bottle of 30)

Zyprexa 2.5 mg Olanzapine Tablets packaging label showing a carton for a 30-tablet bottle. The label includes the NDC number 61269-630-30, the indication for prescription use, and the distributor H2-Pharma LLC. The label also references Cheplapharm as the licensor and includes storage instructions and a barcode.*

FDA Label Image

Package Label (ZYPREXA 20 mg tablet, bottle of 30, trade)

Label for ZyPREXA Olanzapine Tablets 20 mg, a prescription oral tablet product. The label states the kit contains 30 tablets. Distributed by H2-Pharma LLC, Montgomery, AL. The product is licensed by CHEPLAPHARM Registration GmbH, product of Ireland. The label includes instructions for storage and a barcode with NDC 61269-635-30.*

FDA Label Image

Package Label (ZYPREXA 5 mg tablet, bottle of 30)

Label for Zyprexa 5 mg oral tablets with the active ingredient Olanzapine. The label indicates a package of 30 tablets, marketed by CHEPLAPHARM and distributed by H2-Pharma LLC. It includes storage instructions and a warning not to use if the inner seal is missing or broken. The NDC is 61269-631-30.*

FDA Label Image

Package Label (ZYPREXA 7.5 mg tablet, bottle of 30)

Label for Zyprexa 7.5 mg tablets by Cheplapharm, containing 30 tablets. The label features the product name prominently with 'Olanzapine Tablets' noted below. It includes the NDC 61269-632-30 and details storage instructions, warnings about the inner seal, and manufacturer information listing H2-Pharma LLC and Cheplapharm.*

FDA Label Image

Package Label (ZYPREXA INTRAMUSCULAR 10 mg/vial)

Zyprexa IntraMuscular 10 mg/vial (Olanzapine) sterile single-dose vial label. Distributed by H2-Pharma LLC, this intramuscular injection vial contains 10 mg olanzapine. The label includes storage and reconstitution instructions, inactive ingredients, and licensing by CHEPLAPHARM Registration GmbH, Germany. Barcode and product codes are also visible.*

FDA Label Image

Package Label (ZYPREXA ZYDIS 10 mg tablet, 30 sachets)

Packaging label for Zyprexa Zydis 10 mg orally disintegrating tablets, containing Olanzapine. The label includes dosage instructions with illustrations for peeling back the foil blister to remove the tablet, storage information, and a warning not to open the pouch until immediately prior to use. Distributed by H2-Pharma LLC and manufactured by CHEPLAPHARM, the label also notes phenylketonurics warning and features the 10 mg strength prominently.*

FDA Label Image

Package Label (ZYPREXA ZYDIS 15 mg tablet, 30 sachets)

Packaging label for Zyprexa Zydis 15 mg orally disintegrating tablets containing olanzapine. The label includes dosage strength, administration instructions with illustrations, warnings for phenylketonurics, and storage conditions. The product is distributed by H2-Pharma LLC and manufactured by CHEPLAPHARM. Barcode and regulatory information are also present.*

FDA Label Image

Package Label (ZYPREXA ZYDIS 20 mg tablet, 30 sachets, trade)

Packaging label for Zyprexa Zydis 20 mg orally disintegrating tablets by H2-Pharma LLC. The label includes the product name, strength 20 mg, dosage form as orally disintegrating tablets, and contains 30 sachets. Instructions for use are depicted with illustrations, and the label notes the presence of phenylalanine and storage conditions. Manufactured by CHEPLAPHARM.*

FDA Label Image

Package Label (ZYPREXA ZYDIS 5 mg tablet, 30 sachets)

Packaging label for Zyprexa Zydis 5 mg orally disintegrating tablets, containing olanzapine. The label shows the brand and generic names prominently, with dosage strength 5 mg and quantity of 30 sachets. The manufacturer H2-Pharma LLC and CHEPLAPHARM logos appear, along with usage instructions illustrated for tablet administration from blister packaging. Storage instructions and warnings for phenylketonurics are visible on the label.*

FDA Label Image

Chemical Structure (Zyprexa F001 V1)

Chemical structure of olanzapine, the active ingredient in Zyprexa. The diagram depicts the molecular arrangement with ring systems including a thiazepine ring and methyl groups attached to the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.